Mediastinal Masses Flashcards
Masses of Anterior/Superior Mediastinal Compartment
- Thymic neoplasm (thymoma, thymic carcinoma, carinoid)
- Lymphoma
- Germ cell tumors (teratoma, seminoma, non-seminoma tumor)
- Thyroid adenoma
- Parathyroid adenoma
Masses of Middle Mediastinal Compartment
- Bronchogenic cyst
- Pericardial cyst
- Enteric cyst
- Lymphoma
Masses of Posterior Mediastinal Compartment
- Neurogenic tumors
- Esophageal/Enteric cyst
- Lymphoma
Clinical presentation of mediastinal masses
- Asymptomatic and incidental (MC)
- Chest pain
- Cough
- Dyspnea
- Pain and Neurologic deficit (neurogenic tumor)
Diagnostic study of choice for mediastinal tumors
CT scan
(location, morphology, relationship to other structures)
Diagnostic approach to small (<5cm) tumors with characteristic features (i.e. thymoma, teratoma, benign cyst)
Surgical resection
Diagnostic approach to large mediastinal tumors
- CT-guided percutaneous biopsy
- Open biopsy
- Cervical mediastinoscopy
- VATS
- Chamberlain mediastinoscopy
- Thoracotomy
Serum tumor markers that much be checked for mediastinal masses (anterior)
- Beta-HCG
- AFP
- LDH
Diagnostic algorithm for anterior mediastinal masses
- CXR
- Chest CT
- Tissue biopsy (percutaneous vs. open)
- Serum tumor markers (Beta-HCG, AFP, LDH)
Tumors are most common in what mediastinal compartment
Anterior compartment
95% of all anterior mediastinal compartment tumors include:
- Four “Ts”
- Thymoma (MC)
- Teratoma (germ cell tumor)
- “Terrible” lymphoma
- Thyroid goiter
MC anterior mediastinal tumor
Thymoma
Clinical presentation of thymoma
- M:F (1:1)
- 30-50 years old
- 50% = asymptomatic/incidental
- 50% = symptomatic (pain, dyspnea, cough, horseness)
Thymoma associated syndroms
- Myasthenia gravis
- Red cell hypoplasia
- Hypogammaglobulinemia
- SLE
- Rheumatoid arthritis
- UC
- Thyroiditis
CT characteristics of benign thymoma
- < 5 cm
- round
- well-circumscribed
CT characteristics of malignant thymoma
- > 5 cm
- Irregular shape
- Invade neighboring structures
TOC for all thymoma
- Complete excision
- En bloc resection
- Pleura
- Pericardium
- Innominate vein
- SVC
- Lung
- Can excise one phrenic nerve and dissect tumor off other
- En bloc resection
MC surgical exposure/approachs for thymectomy
Median sternotomy
Cervical
VATS
Thymoma Staging (5-Yr Survival)
Survival based on Stage
- Stage I (95%)
- completely encapsulated
- Stage II (85%)
- IIa: mediastinal fat/pleura
- IIb: through capsule
- Stage III (70%)
- direct invasion of adjacent organ
- Stage IV (50%)
- IVa: pleura/pericardium mets
- IVb: distant mets
Indications for neoadjuvant/adjuvant therapy
Stage III-IV disease
(Cisplatin-based chemotherapy + XRT)
Neoadjuvant/Adjuvant therapy regimen
Cisplatin-based chemotherapy + XRT
MOA of Myasthenia Gravis
Autoantibodies to ACh receptor
(decreased transmission of AP at the NM junction)
Demographics of Myasthenia Gravis
- 2x MC in women
- 2-3rd decade of life
Myasthenia Gravis Symptoms Grades
- Grade I: focal disease-ocular muscle weakness
- Grade II: Mild-moderate generalized disease
- Grade III: Severe generalized disease
- Grade IV: life-threatening weakness - respiratory failure
Confirmatory tests for MG
Endrophonium (short acting anticholinesterase ) test
ACh Receptor assay
Medical treatment for MG
Pryidostigmine (long-acting anticholinesterase)
Plasmapheresis and IVIg
Indications for thymectomy for MG
- Presence of thymic hyperplasia or thymoma
- 30-50% of patients with thymoma have MG
- 10-15% of patients with MG have a thymoma
- Grade II-III MG
When should thymemctomy NOT be performed for MG
Myasthenic crisis
Grade IV disease